University of Maryland School of Pharmacy, United States
Disclosure information not submitted.
1D-03 - Recombinant Zoster Vaccine and Risk of Incident Guillain-Barré Syndrome in US Adults ≥ 65 Years of Age
Sunday, August 24, 202511:00 AM - 11:15 AM ET
